ZA9811348B - Statin-carboxyalkylether combinations - Google Patents

Statin-carboxyalkylether combinations

Info

Publication number
ZA9811348B
ZA9811348B ZA9811348A ZA9811348A ZA9811348B ZA 9811348 B ZA9811348 B ZA 9811348B ZA 9811348 A ZA9811348 A ZA 9811348A ZA 9811348 A ZA9811348 A ZA 9811348A ZA 9811348 B ZA9811348 B ZA 9811348B
Authority
ZA
South Africa
Prior art keywords
carboxyalkylether
statin
combinations
carboxyalkylether combinations
Prior art date
Application number
ZA9811348A
Other languages
English (en)
Inventor
Charles Larry Bisgaier
Roger Schofield Newton
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA9811348B publication Critical patent/ZA9811348B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
ZA9811348A 1997-12-12 1998-12-10 Statin-carboxyalkylether combinations ZA9811348B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6937597P 1997-12-12 1997-12-12

Publications (1)

Publication Number Publication Date
ZA9811348B true ZA9811348B (en) 1999-06-14

Family

ID=22088573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811348A ZA9811348B (en) 1997-12-12 1998-12-10 Statin-carboxyalkylether combinations

Country Status (30)

Country Link
EP (1) EP1045691B1 (enExample)
JP (1) JP2002508320A (enExample)
KR (1) KR20010033003A (enExample)
AR (1) AR017851A1 (enExample)
AT (1) ATE285762T1 (enExample)
AU (1) AU754089B2 (enExample)
BR (1) BR9813542A (enExample)
CA (1) CA2304612A1 (enExample)
CO (1) CO4970816A1 (enExample)
CR (1) CR5926A (enExample)
CU (1) CU20000140A7 (enExample)
DE (1) DE69828442T2 (enExample)
DK (1) DK1045691T3 (enExample)
ES (1) ES2230733T3 (enExample)
GT (1) GT199800196A (enExample)
HN (1) HN1998000185A (enExample)
HU (1) HUP0004547A3 (enExample)
IL (1) IL135349A0 (enExample)
IS (1) IS2150B (enExample)
MY (1) MY118381A (enExample)
NO (1) NO20002966D0 (enExample)
NZ (1) NZ503982A (enExample)
PA (1) PA8464601A1 (enExample)
PE (1) PE20000017A1 (enExample)
PL (1) PL341066A1 (enExample)
PT (1) PT1045691E (enExample)
SV (1) SV1998000146A (enExample)
UY (1) UY25299A1 (enExample)
WO (1) WO1999030704A1 (enExample)
ZA (1) ZA9811348B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105154A1 (en) 2001-10-24 2003-06-05 Bisgaier Charles Larry Statin-carboxyalkylether combinations
US6861555B2 (en) 2000-01-25 2005-03-01 Warner-Lambert Company Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
KR20010033017A (ko) * 1997-12-12 2001-04-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 과지질혈증 치료제인 스타틴-ＬＰ(ａ) 억제제의 병용 제제
SK4122001A3 (en) * 1998-09-30 2002-06-04 Warner Lambert Co Method for preventing or delaying catheter-based revascularization
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
IN191580B (enExample) * 1999-12-17 2003-12-06 Ranbaxy Lab Ltd
GEP20053428B (en) 2000-01-25 2005-01-25 Warner Lambert Co Calcium Dicarboxylate Ethers, Methods of Making Same, and Treatment of Vascular Disease and Diabetes Therewith
AU2001256278A1 (en) * 2000-04-18 2001-10-30 Bayer Aktiengesellschaft Use of cse inhibitors for treating heart failure
SK15132002A3 (sk) * 2000-04-26 2003-08-05 Warner-Lambert Company Antihypertenzné činidlá a ich použitie
US6689807B1 (en) * 2000-06-08 2004-02-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. HMG CoA reductase inhibitors for promoting angiogenesis
HUP0500616A3 (en) * 2001-08-16 2011-07-28 Teva Pharma Processes for preparing calcium salt forms of statins
KR20040026705A (ko) 2001-08-16 2004-03-31 테바 파마슈티컬 인더스트리즈 리미티드 스타틴의 칼슘 염 형태의 제조 방법
US20050026979A1 (en) * 2003-07-31 2005-02-03 Maha Ghazzi Methods for treating inflammation and inflammation-associated diseases with a statin and ether
WO2013103842A1 (en) * 2012-01-06 2013-07-11 Michigan Life Therapeutics, Llc Methods of reducing risk of cardiovascular disease
JP2018536710A (ja) 2015-11-06 2018-12-13 ジェンファイア・セラピューティクス・インコーポレイテッドＧｅｍｐｈｉｒｅ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 混合型脂質異常症の治療

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases

Also Published As

Publication number Publication date
NZ503982A (en) 2002-03-28
CA2304612A1 (en) 1999-06-24
CO4970816A1 (es) 2000-11-07
EP1045691B1 (en) 2004-12-29
JP2002508320A (ja) 2002-03-19
PA8464601A1 (es) 2001-12-14
MY118381A (en) 2004-10-30
ES2230733T3 (es) 2005-05-01
CU20000140A7 (es) 2005-10-19
WO1999030704A1 (en) 1999-06-24
CR5926A (es) 2000-03-06
HUP0004547A2 (hu) 2001-05-28
IL135349A0 (en) 2001-05-20
PL341066A1 (en) 2001-03-26
BR9813542A (pt) 2000-10-10
HN1998000185A (es) 1999-06-02
DE69828442D1 (de) 2005-02-03
UY25299A1 (es) 2001-08-27
PT1045691E (pt) 2005-03-31
IS2150B (is) 2006-10-13
ATE285762T1 (de) 2005-01-15
EP1045691A1 (en) 2000-10-25
AR017851A1 (es) 2001-10-24
DK1045691T3 (da) 2005-03-14
AU1591599A (en) 1999-07-05
DE69828442T2 (de) 2005-06-02
SV1998000146A (es) 1999-09-30
AU754089B2 (en) 2002-11-07
PE20000017A1 (es) 2000-01-20
IS5445A (is) 2000-04-14
GT199800196A (es) 2000-06-03
HUP0004547A3 (en) 2001-12-28
NO20002966L (no) 2000-06-09
NO20002966D0 (no) 2000-06-09
KR20010033003A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
DE69807872D1 (en) Thermoplastisches polyetherurethan
DE69832527D1 (en) Chronographenuhr
HUP0004547A3 (en) Statin-carboxyalkylether combinations
DE69727985D1 (en) Extravasationserkennungsvorrichtung
GB9800963D0 (en) Rail--cam
DE69715258D1 (en) Präzisionshydraulikfutter
DE69812077D1 (en) Anthracyclinglycoside
GB9724908D0 (en) Ski-sling
DE69737400D1 (en) Substituierte naphthopyrane
GB9803317D0 (en) Rockbolts
GB9820170D0 (en) AppliquÚs
GB9815161D0 (en) Phenylazoanilines
GB9706288D0 (en) Riggintag
GB9710425D0 (en) Playing-surface
CA82745S (en) Handleset
CA80851S (en) Thermomter
SI1045691T1 (en) Statin-carboxyalkylether combinations
GB9725119D0 (en) Out-skirts
GB9718670D0 (en) Renovative pipeliner
AU134508S (en) Book-end
AU134246S (en) Shelf-end
AU133791S (en) V-nailer
GB9724658D0 (en) Multiflate mf1-7
GB9701181D0 (en) Glovelette
GB9704446D0 (en) Catupults